FDA approves the use of ADHD patch for teenagers

07/6/2010 | Bloomberg Businessweek

The Food and Drug Administration has approved Shire's Daytrana skin patch to treat patients ages 13 to 17 who have attention-deficit/hyperactivity disorder. The treatment is already available for children ages 6 to 12 with ADHD.

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Education

Job Title Company Location
Technical Assistance Associate (8156)
American Institutes for Research
Washington, DC
Director, Curriculum & Content
Houghton Mifflin Harcourt
Nashville, TN
Senior Technical Assistance Consultant
American Institutes for Research
Washington, DC
Associate Account Executive
Houghton Mifflin Harcourt
Cheyenne, WY
Technical Assistance Consultant
American Institutes for Research
Washington, DC